Practice-changing publications: Kidney cancer.
作者信息
Lavallée Luke T, Kapoor Anil
机构信息
Division of Urology, Department of Surgery, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Division of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
出版信息
Can Urol Assoc J. 2022 May;16(5):E237-E239. doi: 10.5489/cuaj.7862.
Abstract
摘要
相似文献
1
Practice-changing publications: Kidney cancer.改变实践的出版物：肾癌
Can Urol Assoc J. 2022 May;16(5):E237-E239. doi: 10.5489/cuaj.7862.
2
Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2019.门诊普通内科学最新进展：2019 年发表的具有改变实践意义的证据。
Am J Med. 2020 Jul;133(7):789-794. doi: 10.1016/j.amjmed.2020.02.033. Epub 2020 Apr 2.
3
Media Reporting of Practice-Changing Clinical Trials in Oncology: A North American Perspective.肿瘤学中改变实践的临床试验的媒体报道：北美视角
Oncologist. 2016 Mar;21(3):269-78. doi: 10.1634/theoncologist.2015-0056. Epub 2016 Feb 26.
4
When i use a word ... changing your practice.当我使用一个词时……改变你的做法。
不过你提供的原文似乎不太完整或准确，可能会影响理解。
QJM. 2010 Jan;103(1):63-5. doi: 10.1093/qjmed/hcp055. Epub 2009 May 21.
5
A review of kidney motion under free, deep and forced-shallow breathing conditions: implications for stereotactic ablative body radiotherapy treatment.自由、深和强制浅呼吸条件下肾脏运动的综述：对立体定向消融体放射治疗的影响。
Technol Cancer Res Treat. 2014 Aug;13(4):315-23. doi: 10.7785/tcrt.2012.500387. Epub 2013 Dec 6.
6
Evolving Trends in Surgical Management of Breast Cancer: An Analysis of 30 Years of Practice Changing Papers.乳腺癌外科治疗的发展趋势：对30年改变实践的论文的分析
Front Oncol. 2021 Aug 4;11:622621. doi: 10.3389/fonc.2021.622621. eCollection 2021.
7
Practice-changing publications: Male infertility.改变实践的出版物：男性不育症
Can Urol Assoc J. 2022 Feb;16(2):13-14. doi: 10.5489/cuaj.7734.
8
Practice-changing publications: Update in the management of urolithaisis.改变实践的出版物：尿石症管理的最新进展
Can Urol Assoc J. 2021 Aug;15(8):227-229. doi: 10.5489/cuaj.7486.
9
Practice-changing publications: Pediatric urology - focus on treatment of spina bifida.改变实践的出版物：小儿泌尿外科——聚焦脊柱裂的治疗
Can Urol Assoc J. 2021 Oct;15(10):324-325. doi: 10.5489/cuaj.7590.
10
Practice-changing publications in functional urology: A case-based approach.功能性泌尿外科学中改变实践的出版物：基于病例的方法。
Can Urol Assoc J. 2021 Jul;15(7):E330-E334. doi: 10.5489/cuaj.7468.
本文引用的文献
1
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.贝伐珠单抗治疗 von Hippel-Lindau 病相关肾细胞癌
N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425.
2
Evidence-based Urology: Surrogate Endpoints - Con.循证泌尿外科学：替代终点-续。
Eur Urol Focus. 2021 Nov;7(6):1219-1221. doi: 10.1016/j.euf.2021.10.008. Epub 2021 Oct 23.
3
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.肾细胞癌肾切除术后辅助帕博利珠单抗。
N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391.
4
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?舒尼替尼单药治疗或肾切除术治疗转移性肾细胞癌患者：细胞减积性肾切除术是否仍有作用？
Eur Urol. 2021 Oct;80(4):417-424. doi: 10.1016/j.eururo.2021.06.009. Epub 2021 Jun 27.
5
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.晚期肾癌的管理：加拿大肾癌研究网络（KCRNC）2021年共识更新
Can Urol Assoc J. 2021 Apr;15(4):84-97. doi: 10.5489/cuaj.7245.
6
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.纳武利尤单抗联合卡博替尼对比舒尼替尼用于晚期肾细胞癌。
N Engl J Med. 2021 Mar 4;384(9):829-841. doi: 10.1056/NEJMoa2026982.
7
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.仑伐替尼联合帕博利珠单抗或依维莫司治疗晚期肾细胞癌。
N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13.
8
Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled Trial.肾肿瘤患者部分肾切除术中低温：一项随机对照试验。
J Urol. 2021 May;205(5):1303-1309. doi: 10.1097/JU.0000000000001517. Epub 2020 Dec 21.
9
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial.纳武利尤单抗联合伊匹木单抗与舒尼替尼一线治疗晚期肾细胞癌：III期CheckMate 214试验的4年延长随访
ESMO Open. 2020 Nov;5(6):e001079. doi: 10.1136/esmoopen-2020-001079.
10
Shared decision-making for the management of small renal masses: Development and acceptability testing of a novel patient decision aid.小肾肿块管理的共同决策：一种新型患者决策辅助工具的开发与可接受性测试
Can Urol Assoc J. 2020 Dec;14(12):385-391. doi: 10.5489/cuaj.6575.
Zotero 插件